Faron Pharmaceuticals Oy (AIM: FARN)
London
· Delayed Price · Currency is GBP · Price in GBX207.00
-8.00 (-3.72%)
Sep 11, 2024, 4:12 PM GMT+1
Faron Pharmaceuticals Oy Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 29.98 | 6.88 | 6.99 | 6.85 | 4.11 | 7.06 | Upgrade
|
| Cash & Short-Term Investments | 29.98 | 6.88 | 6.99 | 6.85 | 4.11 | 7.06 | Upgrade
|
| Cash Growth | 374.73% | -1.65% | 2.00% | 66.82% | -41.80% | 73.57% | Upgrade
|
| Other Receivables | - | 0.23 | 0.91 | 1.42 | 1.27 | 1.25 | Upgrade
|
| Receivables | - | 0.23 | 0.91 | 1.42 | 1.27 | 1.25 | Upgrade
|
| Prepaid Expenses | 3.99 | 1.76 | 1.84 | 3.75 | 1.99 | 0.9 | Upgrade
|
| Other Current Assets | - | 0 | - | - | - | - | Upgrade
|
| Total Current Assets | 33.97 | 8.87 | 9.73 | 12.02 | 7.37 | 9.2 | Upgrade
|
| Property, Plant & Equipment | 0.35 | 0.2 | 0.33 | 0.21 | 0.38 | 0.4 | Upgrade
|
| Other Intangible Assets | 1.09 | 1.09 | 1.15 | 0.9 | 0.57 | 0.53 | Upgrade
|
| Other Long-Term Assets | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.08 | Upgrade
|
| Total Assets | 35.46 | 10.22 | 11.27 | 13.18 | 8.37 | 10.21 | Upgrade
|
| Accounts Payable | 17.47 | 8.97 | 6.01 | 2.23 | 2.12 | 2.97 | Upgrade
|
| Accrued Expenses | 2.24 | 2.4 | 2.45 | 4.06 | 3.82 | 2.43 | Upgrade
|
| Current Portion of Long-Term Debt | 3.67 | 3.48 | 1.85 | 0.43 | 0.12 | 0.16 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.16 | 0.15 | 0.18 | 0.18 | 0.14 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.28 | 0.27 | 0.38 | Upgrade
|
| Total Current Liabilities | 23.49 | 15.01 | 10.47 | 7.18 | 6.5 | 6.08 | Upgrade
|
| Long-Term Debt | 8.71 | 9.42 | 11.1 | 2.92 | 2.73 | 2.26 | Upgrade
|
| Long-Term Leases | 0.24 | 0.05 | 0.16 | 0.02 | 0.2 | 0.26 | Upgrade
|
| Other Long-Term Liabilities | 1.64 | 0.9 | 1.01 | 0.15 | 0.79 | - | Upgrade
|
| Total Liabilities | 34.08 | 25.38 | 22.75 | 10.26 | 10.22 | 8.6 | Upgrade
|
| Common Stock | 2.69 | 2.69 | 2.69 | 2.69 | 2.69 | 2.69 | Upgrade
|
| Retained Earnings | -186.18 | -172.21 | -143.71 | -116.27 | -96.56 | -80 | Upgrade
|
| Comprensive Income & Other | 184.87 | 154.36 | 129.55 | 116.49 | 92.02 | 78.92 | Upgrade
|
| Shareholders' Equity | 1.38 | -15.16 | -11.48 | 2.92 | -1.85 | 1.61 | Upgrade
|
| Total Liabilities & Equity | 35.46 | 10.22 | 11.27 | 13.18 | 8.37 | 10.21 | Upgrade
|
| Total Debt | 12.72 | 13.11 | 13.27 | 3.55 | 3.23 | 2.82 | Upgrade
|
| Net Cash (Debt) | 17.26 | -6.24 | -6.28 | 3.31 | 0.88 | 4.24 | Upgrade
|
| Net Cash Growth | - | - | - | 274.41% | -79.16% | 118.97% | Upgrade
|
| Net Cash Per Share | 0.25 | -0.10 | -0.11 | 0.07 | 0.02 | 0.11 | Upgrade
|
| Filing Date Shares Outstanding | 104.62 | 68.79 | 59.81 | 53.23 | 46.9 | 43.29 | Upgrade
|
| Total Common Shares Outstanding | 104.62 | 68.79 | 59.81 | 53.23 | 46.9 | 43.29 | Upgrade
|
| Working Capital | 10.47 | -6.14 | -0.74 | 4.85 | 0.87 | 3.13 | Upgrade
|
| Book Value Per Share | 0.01 | -0.22 | -0.19 | 0.05 | -0.04 | 0.04 | Upgrade
|
| Tangible Book Value | 0.29 | -16.25 | -12.63 | 2.02 | -2.41 | 1.08 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | -0.24 | -0.21 | 0.04 | -0.05 | 0.02 | Upgrade
|
| Machinery | - | 0.03 | 0.06 | 0.06 | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.